HMS News article on new research from the labs of Tomas Kirchhausen and colleagues, co-first authors Mootaz Salman, Philip Kitchen, and Andrea Halsey, demonstrating that a drug which reduces swelling after brain or spinal cord injury—via its impact on aquaporin proteins—may protect against long term sensory and motor deficits.